Sugi Predict

Sugi Predict / Compounds / SCHEMBL29496367

SCHEMBL29496367

SCHEMBL29496367

CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CS)C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ PTH1R Q03431 8/20 0.57
▸ RXFP1 Q9HBX9 1/20 0.55
▸ TFPI P10646 1/20 0.52
▸ KEAP1 Q14145 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31332307 1.00 PTH1R (0.57) PTH1RRXFP1TFPIKEAP1
SCHEMBL31332065 0.95 PTH1R (0.60) PTH1RRXFP1KEAP1
SCHEMBL31332037 0.95 TFPI (0.55) PTH1RRXFP1TFPIKEAP1
SCHEMBL29863200 0.94 PTH1R (0.61) PTH1RRXFP1TFPIKEAP1
SCHEMBL29777401 0.94 PTH1R (0.54) PTH1RTFPIKEAP1
SCHEMBL29863068 0.92 PTH1R (0.62) PTH1RRXFP1TFPI
SCHEMBL29862843 0.92 PTH1R (0.57) PTH1RRXFP1
SCHEMBL31332249 0.91 PTH1R (0.55) PTH1RTFPI
SCHEMBL31332423 0.91 PTH1R (0.55) PTH1RTFPI
SCHEMBL29939684 0.90 TFPI (0.57) TFPIKEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240376153-A1 CNP CYCLIC PEPTIDE, AND MEDICINE, EXTERNAL PREPARATION AND COSMETIC EACH CONTAINING SAID CYCLIC PEPTIDE IGISU CO., LTD. (JP) 2024-11-14 — — US disclosed
CN-114269323-B Hydrophilic linkers for multivalent peptide conjugates 瓦利托尔有限公司 2024-07-26 — — CN disclosed
CN-114269323-A Hydrophilic linkers for multivalent peptide conjugates 瓦利托尔有限公司 2022-04-01 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240376153-A1 CNP CYCLIC PEPTIDE, AND MEDICINE, EXTERNAL PREPARATION AND COSMETIC EACH CONTAINING SAID CYCLIC PEPTIDE NPR1, CNP, NPR3 PTH1R 236/4885RXFP1 117/4885TFPI 3512/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback